Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Beyond Lipids: The Role in Oxidative Stress and Thrombosis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Beyond Lipids: The Role in Oxidative Stress and Thrombosis
Authors
Keywords
-
Journal
Antioxidants
Volume 11, Issue 3, Pages 569
Publisher
MDPI AG
Online
2022-03-17
DOI
10.3390/antiox11030569
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Antioxidants Supplementation in Clinical Practice: Focus on Cardiovascular Risk Factors
- (2021) Vittoria Cammisotto et al. Antioxidants
- Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways
- (2021) Vittoria Cammisotto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association between PCSK9 Levels and Markers of Inflammation, Oxidative Stress, and Endothelial Dysfunction in a Population of Nondialysis Chronic Kidney Disease Patients
- (2021) Evangelia Dounousi et al. Oxidative Medicine and Cellular Longevity
- Soluble Platelet Release Factors as Biomarkers for Cardiovascular Disease
- (2021) Gaukhar Baidildinova et al. Frontiers in Cardiovascular Medicine
- Platelet-Derived PCSK9 Is Associated with LDL Metabolism and Modulates Atherothrombotic Mechanisms in Coronary Artery Disease
- (2021) Álvaro Petersen-Uribe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
- (2020) Jan Borén et al. EUROPEAN HEART JOURNAL
- Familial hypercholesterolaemia and COVID‐19: triggering of increased sustained cardiovascular risk
- (2020) Alpo Vuorio et al. JOURNAL OF INTERNAL MEDICINE
- PCSK9 Regulates Nox2-Mediated Platelet Activation via CD36 Receptor in Patients with Atrial Fibrillation
- (2020) Vittoria Cammisotto et al. Antioxidants
- Statins and PCSK9 inhibitors: A new lipid-lowering therapy
- (2020) Enrique Gallego-Colon et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Evolocumab, a PCSK9 inhibitor, protects human endothelial cells against H2O2-induced oxidative stress
- (2020) Leila Safaeian et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- PCSK9 Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36
- (2020) Zhiyong Qi et al. CIRCULATION
- PCSK9 and atherosclerosis: Looking beyond LDL regulation
- (2020) Rosetta Ragusa et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation: A post-hoc analysis from the ATHERO-AF cohort
- (2019) Daniele Pastori et al. ATHEROSCLEROSIS
- CD36 and ERK5 link dyslipidemia to apoptotic-like platelet procoagulant function
- (2019) Moua Yang et al. CURRENT OPINION IN HEMATOLOGY
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
- (2019) Stavros V Konstantinides et al. EUROPEAN HEART JOURNAL
- Platelet function and activation markers in primary hypercholesterolemia treated with PCSK9 monoclonal antibody: a 12-month follow-up
- (2019) Cristina Barale et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease
- (2019) Ji Soo Lee et al. Scientific Reports
- PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages
- (2018) Zufeng Ding et al. CARDIOVASCULAR RESEARCH
- PCSK9 as a Positive Modulator of Platelet Activation
- (2018) Marina Camera et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Contribution of lectin-like oxidized low-density lipoprotein receptor-1 and LOX-1 modulating compounds to vascular diseases
- (2018) Anja Hofmann et al. VASCULAR PHARMACOLOGY
- Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk
- (2018) Paul M Ridker JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma redox imbalance caused by albumin oxidation promotes lung-predominant NETosis and pulmonary cancer metastasis
- (2018) Minoru Inoue et al. Nature Communications
- Dyslipidemia induced inflammatory status, platelet activation and endothelial dysfunction in rabbits: Protective role of 10-Dehydrogingerdione
- (2018) Mohamed Mahmoud El-Seweidy et al. BIOMEDICINE & PHARMACOTHERAPY
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study
- (2017) Eliano P. Navarese et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation
- (2017) Daniele Pastori et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oxidative Stress: Harms and Benefits for Human Health
- (2017) Gabriele Pizzino et al. Oxidative Medicine and Cellular Longevity
- NADPH Oxidase-2 and AtherothrombosisHighlights
- (2016) Francesco Violi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study
- (2016) Jin M. Cheng et al. ATHEROSCLEROSIS
- From Lipids to Inflammation
- (2016) Michael D. Shapiro et al. CIRCULATION RESEARCH
- Role of ROS and RNS Sources in Physiological and Pathological Conditions
- (2016) Sergio Di Meo et al. Oxidative Medicine and Cellular Longevity
- Hemodynamic Shear Stress via ROS Modulates PCSK9 Expression in Human Vascular Endothelial and Smooth Muscle Cells and Along the Mouse Aorta
- (2015) Zufeng Ding et al. ANTIOXIDANTS & REDOX SIGNALING
- Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade
- (2015) S. Magwenzi et al. BLOOD
- Cross-talk between LOX-1 and PCSK9 in vascular tissues
- (2015) Zufeng Ding et al. CARDIOVASCULAR RESEARCH
- Prognostic value of PCSK9 levels in patients with acute coronary syndromes
- (2015) Baris Gencer et al. EUROPEAN HEART JOURNAL
- The Relationship between the Plasma PCSK9 Levels and Platelet Indices in Patients with Stable Coronary Artery Disease
- (2015) Sha Li et al. Journal of Atherosclerosis and Thrombosis
- PCSK9: A key factor modulating atherosclerosis
- (2015) Sha Li et al. Journal of Atherosclerosis and Thrombosis
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
- (2015) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism
- (2014) Roberto Carnevale et al. ATHEROSCLEROSIS
- Emerging roles for platelets as immune and inflammatory cells
- (2014) C. N. Morrell et al. BLOOD
- Pathophysiology of Acute Coronary Syndrome
- (2014) Carlos G. Santos-Gallego et al. Current Atherosclerosis Reports
- Platelets Mediate Oxidized Low-Density Lipoprotein–Induced Monocyte Extravasation and Foam Cell Formation
- (2013) Sigrun Badrnya et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effect of Plasma Uric Acid on Antioxidant Capacity, Oxidative Stress, and Insulin Sensitivity in Obese Subjects
- (2013) E. Fabbrini et al. DIABETES
- The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol
- (2013) Gaétan Mayer et al. Drug Design Development and Therapy
- LOX-1
- (2012) Tatsuya Sawamura et al. CURRENT OPINION IN LIPIDOLOGY
- Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo
- (2012) Marie-Luise von Brühl et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Proceedings of a Canadian Working Group Consensus Conference
- (2011) G.B. John Mancini et al. CANADIAN JOURNAL OF CARDIOLOGY
- Nutrition, Supplements, and Vitamins in Platelet Function and Bleeding
- (2010) Francesco Violi et al. CIRCULATION
- Generation and Biological Activities of Oxidized Phospholipids
- (2009) Valery N. Bochkov et al. ANTIOXIDANTS & REDOX SIGNALING
- Endothelium, venous thromboembolism and ischaemic cardiovascular events
- (2009) P. Gresele et al. THROMBOSIS AND HAEMOSTASIS
- Glutathione: Overview of its protective roles, measurement, and biosynthesis
- (2008) Henry Jay Forman et al. MOLECULAR ASPECTS OF MEDICINE
- Mechanisms of Thrombus Formation
- (2008) Bruce Furie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: An Italian multicenter study
- (2007) Baldassarre Martire et al. CLINICAL IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search